Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Tbx3-Mediated Regulation of Cardiac Conduction System Development and Function: Potential Contributions of Alternative RNA Processing.

Delisle BP, Yu Y, Puvvula P, Hall AR, Huff C, Moon AM.

Pediatr Cardiol. 2019 Oct;40(7):1388-1400. doi: 10.1007/s00246-019-02166-4. Epub 2019 Aug 1. Review.

PMID:
31372681
2.

Editorial: Ion Channel Trafficking and Cardiac Arrhythmias.

van der Heyden MAG, Delisle BP, Abriel H.

Front Physiol. 2018 Sep 25;9:1254. doi: 10.3389/fphys.2018.01254. eCollection 2018. No abstract available.

3.

Visualizing Mutation-Specific Differences in the Trafficking-Deficient Phenotype of Kv11.1 Proteins Linked to Long QT Syndrome Type 2.

Hall AR, Anderson CL, Smith JL, Mirshahi T, Elayi CS, January CT, Delisle BP.

Front Physiol. 2018 May 23;9:584. doi: 10.3389/fphys.2018.00584. eCollection 2018.

4.

Functional Invalidation of Putative Sudden Infant Death Syndrome-Associated Variants in the KCNH2-Encoded Kv11.1 Channel.

Smith JL, Tester DJ, Hall AR, Burgess DE, Hsu CC, Elayi SC, Anderson CL, January CT, Luo JZ, Hartzel DN, Mirshahi UL, Murray MF, Mirshahi T, Ackerman MJ, Delisle BP.

Circ Arrhythm Electrophysiol. 2018 May;11(5):e005859. doi: 10.1161/CIRCEP.117.005859.

PMID:
29752375
5.

Functional Neuroplasticity in the Nucleus Tractus Solitarius and Increased Risk of Sudden Death in Mice with Acquired Temporal Lobe Epilepsy.

Derera ID, Delisle BP, Smith BN.

eNeuro. 2017 Oct 30;4(5). pii: ENEURO.0319-17.2017. doi: 10.1523/ENEURO.0319-17.2017. eCollection 2017 Sep-Oct.

6.

Advancing precision medicine for the treatment of long-QT syndrome type 2: shedding light on lumacaftor.

Delisle BP, January CT.

Eur Heart J. 2018 Apr 21;39(16):1456-1458. doi: 10.1093/eurheartj/ehx561. No abstract available.

PMID:
29040441
7.

Electronic health record phenotype in subjects with genetic variants associated with arrhythmogenic right ventricular cardiomyopathy: a study of 30,716 subjects with exome sequencing.

Haggerty CM, James CA, Calkins H, Tichnell C, Leader JB, Hartzel DN, Nevius CD, Pendergrass SA, Person TN, Schwartz M, Ritchie MD, Carey DJ, Ledbetter DH, Williams MS, Dewey FE, Lopez A, Penn J, Overton JD, Reid JG, Lebo M, Mason-Suares H, Austin-Tse C, Rehm HL, Delisle BP, Makowski DJ, Mehra VC, Murray MF, Fornwalt BK.

Genet Med. 2017 Nov;19(11):1245-1252. doi: 10.1038/gim.2017.40. Epub 2017 May 4.

8.

Potassium channels in the heart: structure, function and regulation.

Grandi E, Sanguinetti MC, Bartos DC, Bers DM, Chen-Izu Y, Chiamvimonvat N, Colecraft HM, Delisle BP, Heijman J, Navedo MF, Noskov S, Proenza C, Vandenberg JI, Yarov-Yarovoy V.

J Physiol. 2017 Apr 1;595(7):2209-2228. doi: 10.1113/JP272864. Epub 2016 Nov 13. Review.

9.

The Promise and Peril of Precision Medicine: Phenotyping Still Matters Most.

Ackerman JP, Bartos DC, Kapplinger JD, Tester DJ, Delisle BP, Ackerman MJ.

Mayo Clin Proc. 2016 Oct 8. pii: S0025-6196(16)30463-3. doi: 10.1016/j.mayocp.2016.08.008. [Epub ahead of print] Review.

10.

Molecular pathogenesis of long QT syndrome type 2.

Smith JL, Anderson CL, Burgess DE, Elayi CS, January CT, Delisle BP.

J Arrhythm. 2016 Oct;32(5):373-380. Epub 2016 Jan 22. Review.

11.

A snapshot in time: Does exercise training impact the muscle circadian clock in patients?

Schroder EA, Delisle BP.

Eur J Prev Cardiol. 2016 Sep;23(13):1372-4. doi: 10.1177/2047487316651839. Epub 2016 May 26. No abstract available.

PMID:
27231397
12.

The Long and the Short of It: Seizures Induce Cardiac Remodeling and Arrhythmia.

Smith BN, Delisle BP.

Epilepsy Curr. 2015 Mar-Apr;15(2):90-1. doi: 10.5698/1535-7597-15.2.90. No abstract available.

13.

The cardiomyocyte molecular clock regulates the circadian expression of Kcnh2 and contributes to ventricular repolarization.

Schroder EA, Burgess DE, Zhang X, Lefta M, Smith JL, Patwardhan A, Bartos DC, Elayi CS, Esser KA, Delisle BP.

Heart Rhythm. 2015 Jun;12(6):1306-14. doi: 10.1016/j.hrthm.2015.02.019. Epub 2015 Feb 19.

14.

Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome.

Anderson CL, Kuzmicki CE, Childs RR, Hintz CJ, Delisle BP, January CT.

Nat Commun. 2014 Nov 24;5:5535. doi: 10.1038/ncomms6535.

15.

Light phase-restricted feeding slows basal heart rate to exaggerate the type-3 long QT syndrome phenotype in mice.

Schroder EA, Burgess DE, Manning CL, Zhao Y, Moss AJ, Patwardhan A, Elayi CS, Esser KA, Delisle BP.

Am J Physiol Heart Circ Physiol. 2014 Dec 15;307(12):H1777-85. doi: 10.1152/ajpheart.00341.2014. Epub 2014 Oct 24.

16.

A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation.

Bartos DC, Giudicessi JR, Tester DJ, Ackerman MJ, Ohno S, Horie M, Gollob MH, Burgess DE, Delisle BP.

Heart Rhythm. 2014 Mar;11(3):459-68. doi: 10.1016/j.hrthm.2013.11.021. Epub 2013 Nov 21.

17.

A molecular mechanism for adrenergic-induced long QT syndrome.

Wu J, Naiki N, Ding WG, Ohno S, Kato K, Zang WJ, Delisle BP, Matsuura H, Horie M.

J Am Coll Cardiol. 2014 Mar 4;63(8):819-27. doi: 10.1016/j.jacc.2013.08.1648. Epub 2013 Oct 30.

18.

A novel KCNQ1 missense mutation identified in a patient with juvenile-onset atrial fibrillation causes constitutively open IKs channels.

Hasegawa K, Ohno S, Ashihara T, Itoh H, Ding WG, Toyoda F, Makiyama T, Aoki H, Nakamura Y, Delisle BP, Matsuura H, Horie M.

Heart Rhythm. 2014 Jan;11(1):67-75. doi: 10.1016/j.hrthm.2013.09.073. Epub 2013 Oct 1.

PMID:
24096004
19.

Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum.

Smith JL, Reloj AR, Nataraj PS, Bartos DC, Schroder EA, Moss AJ, Ohno S, Horie M, Anderson CL, January CT, Delisle BP.

Am J Physiol Cell Physiol. 2013 Nov 1;305(9):C919-30. doi: 10.1152/ajpcell.00406.2012. Epub 2013 Jul 17.

20.

Long QT syndrome-associated mutations in intrauterine fetal death.

Crotti L, Tester DJ, White WM, Bartos DC, Insolia R, Besana A, Kunic JD, Will ML, Velasco EJ, Bair JJ, Ghidoni A, Cetin I, Van Dyke DL, Wick MJ, Brost B, Delisle BP, Facchinetti F, George AL, Schwartz PJ, Ackerman MJ.

JAMA. 2013 Apr 10;309(14):1473-82. doi: 10.1001/jama.2013.3219.

21.

Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.

McBride CM, Smith AM, Smith JL, Reloj AR, Velasco EJ, Powell J, Elayi CS, Bartos DC, Burgess DE, Delisle BP.

J Membr Biol. 2013 May;246(5):355-64. doi: 10.1007/s00232-013-9539-6. Epub 2013 Apr 2.

22.

The cardiomyocyte molecular clock, regulation of Scn5a, and arrhythmia susceptibility.

Schroder EA, Lefta M, Zhang X, Bartos DC, Feng HZ, Zhao Y, Patwardhan A, Jin JP, Esser KA, Delisle BP.

Am J Physiol Cell Physiol. 2013 May 15;304(10):C954-65. doi: 10.1152/ajpcell.00383.2012. Epub 2013 Jan 30.

23.

A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation.

Bartos DC, Anderson JB, Bastiaenen R, Johnson JN, Gollob MH, Tester DJ, Burgess DE, Homfray T, Behr ER, Ackerman MJ, Guicheney P, Delisle BP.

J Cardiovasc Electrophysiol. 2013 May;24(5):562-9. doi: 10.1111/jce.12068. Epub 2013 Jan 25.

24.

Mechanism of loss of Kv11.1 K+ current in mutant T421M-Kv11.1-expressing rat ventricular myocytes: interaction of trafficking and gating.

Balijepalli SY, Lim E, Concannon SP, Chew CL, Holzem KE, Tester DJ, Ackerman MJ, Delisle BP, Balijepalli RC, January CT.

Circulation. 2012 Dec 11;126(24):2809-18. doi: 10.1161/CIRCULATIONAHA.112.118018. Epub 2012 Nov 6.

25.

High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the molecular basis for rapid K(+) permeation.

Burgess DE, Bartos DC, Reloj AR, Campbell KS, Johnson JN, Tester DJ, Ackerman MJ, Fressart V, Denjoy I, Guicheney P, Moss AJ, Ohno S, Horie M, Delisle BP.

Biochemistry. 2012 Nov 13;51(45):9076-85. doi: 10.1021/bi3009449. Epub 2012 Nov 2.

26.

Trafficking-deficient hERG K⁺ channels linked to long QT syndrome are regulated by a microtubule-dependent quality control compartment in the ER.

Smith JL, McBride CM, Nataraj PS, Bartos DC, January CT, Delisle BP.

Am J Physiol Cell Physiol. 2011 Jul;301(1):C75-85. doi: 10.1152/ajpcell.00494.2010. Epub 2011 Apr 13.

27.

Small GTPase Rab11b regulates degradation of surface membrane L-type Cav1.2 channels.

Best JM, Foell JD, Buss CR, Delisle BP, Balijepalli RC, January CT, Kamp TJ.

Am J Physiol Cell Physiol. 2011 May;300(5):C1023-33. doi: 10.1152/ajpcell.00288.2010. Epub 2011 Jan 19.

28.

R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation.

Bartos DC, Duchatelet S, Burgess DE, Klug D, Denjoy I, Peat R, Lupoglazoff JM, Fressart V, Berthet M, Ackerman MJ, January CT, Guicheney P, Delisle BP.

Heart Rhythm. 2011 Jan;8(1):48-55. doi: 10.1016/j.hrthm.2010.09.010. Epub 2010 Sep 17.

29.

Properties of WT and mutant hERG K(+) channels expressed in neonatal mouse cardiomyocytes.

Lin EC, Holzem KM, Anson BD, Moungey BM, Balijepalli SY, Tester DJ, Ackerman MJ, Delisle BP, Balijepalli RC, January CT.

Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H1842-9. doi: 10.1152/ajpheart.01236.2009. Epub 2010 Apr 2.

30.

Small GTPase determinants for the Golgi processing and plasmalemmal expression of human ether-a-go-go related (hERG) K+ channels.

Delisle BP, Underkofler HA, Moungey BM, Slind JK, Kilby JA, Best JM, Foell JD, Balijepalli RC, Kamp TJ, January CT.

J Biol Chem. 2009 Jan 30;284(5):2844-53. doi: 10.1074/jbc.M807289200. Epub 2008 Nov 24.

31.

Kv11.1 (ERG1) K+ channels localize in cholesterol and sphingolipid enriched membranes and are modulated by membrane cholesterol.

Balijepalli RC, Delisle BP, Balijepalli SY, Foell JD, Slind JK, Kamp TJ, January CT.

Channels (Austin). 2007 Jul-Aug;1(4):263-72. Epub 2007 Aug 27.

PMID:
18708743
32.

Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome.

Amin AS, Herfst LJ, Delisle BP, Klemens CA, Rook MB, Bezzina CR, Underkofler HA, Holzem KM, Ruijter JM, Tan HL, January CT, Wilde AA.

J Clin Invest. 2008 Jul;118(7):2552-61. doi: 10.1172/JCI35337.

33.

Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome.

Takemasa H, Nagatomo T, Abe H, Kawakami K, Igarashi T, Tsurugi T, Kabashima N, Tamura M, Okazaki M, Delisle BP, January CT, Otsuji Y.

Br J Pharmacol. 2008 Feb;153(3):439-47. Epub 2007 Oct 29.

34.

Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.

Rajamani S, Eckhardt LL, Valdivia CR, Klemens CA, Gillman BM, Anderson CL, Holzem KM, Delisle BP, Anson BD, Makielski JC, January CT.

Br J Pharmacol. 2006 Nov;149(5):481-9. Epub 2006 Sep 11.

35.

Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.

Anderson CL, Delisle BP, Anson BD, Kilby JA, Will ML, Tester DJ, Gong Q, Zhou Z, Ackerman MJ, January CT.

Circulation. 2006 Jan 24;113(3):365-73.

PMID:
16432067
36.

Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.

Kawakami K, Nagatomo T, Abe H, Kikuchi K, Takemasa H, Anson BD, Delisle BP, January CT, Nakashima Y.

Br J Pharmacol. 2006 Mar;147(6):642-52.

37.

Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome.

Delisle BP, Slind JK, Kilby JA, Anderson CL, Anson BD, Balijepalli RC, Tester DJ, Ackerman MJ, Kamp TJ, January CT.

Mol Pharmacol. 2005 Jul;68(1):233-40. Epub 2005 Apr 25.

PMID:
15851652
38.

Biology of cardiac arrhythmias: ion channel protein trafficking.

Delisle BP, Anson BD, Rajamani S, January CT.

Circ Res. 2004 Jun 11;94(11):1418-28. Review.

PMID:
15192037
39.

Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels.

Anson BD, Ackerman MJ, Tester DJ, Will ML, Delisle BP, Anderson CL, January CT.

Am J Physiol Heart Circ Physiol. 2004 Jun;286(6):H2434-41. Epub 2004 Feb 19.

40.

Molecular heterogeneity of calcium channel beta-subunits in canine and human heart: evidence for differential subcellular localization.

Foell JD, Balijepalli RC, Delisle BP, Yunker AM, Robia SL, Walker JW, McEnery MW, January CT, Kamp TJ.

Physiol Genomics. 2004 Apr 13;17(2):183-200.

PMID:
14762176
41.

Monovalent cations contribute to T-type calcium channel (Cav3.1 and Cav3.2) selectivity.

Delisle BP, Satin J.

J Membr Biol. 2003 Jun 1;193(3):185-94.

PMID:
12962279
42.

Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C.

Delisle BP, Anderson CL, Balijepalli RC, Anson BD, Kamp TJ, January CT.

J Biol Chem. 2003 Sep 12;278(37):35749-54. Epub 2003 Jul 1.

43.

Genetic basis for the origin of cardiac arrhythmias: implications for therapy.

Mbai M, Rajamani S, Delisle BP, Anson BD, Anderson C, Makielski JC, January CT.

Curr Cardiol Rep. 2002 Sep;4(5):411-7. Review.

PMID:
12169238
44.

Mechanism of inactivation gating of human T-type (low-voltage activated) calcium channels.

Burgess DE, Crawford O, Delisle BP, Satin J.

Biophys J. 2002 Apr;82(4):1894-906.

45.

Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart.

Cribbs LL, Martin BL, Schroder EA, Keller BB, Delisle BP, Satin J.

Circ Res. 2001 Mar 2;88(4):403-7.

PMID:
11230107
46.

pH modification of human T-type calcium channel gating.

Delisle BP, Satin J.

Biophys J. 2000 Apr;78(4):1895-905.

Supplemental Content

Loading ...
Support Center